Back

Magnetic resonance guided stereotactic radioablation for septal ventricular tachycardias

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Ventricular arrhythmias catheter ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Michele Magnocavallo

Fatebenefratelli Isola Tiberina Hospital, Rome (Italy)

5 More presentations in this session

Presentation thumbnail
Acute success of focal pulsed field ablation for the treatment of premature ventricular outflow tract contractions
Doctor A. Keelani (Bad Berka, DE)
Abstract Slides Video
Presentation thumbnail
Early vs. delayed vt ablation in patients with ischemic cardiomyopathy
Doctor A. Maan (Toledo, US)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic imaging to guide VT ablation in structural heart disease
Doctor A. Nunes Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Clinical validation of simulated VT morphologies with clinical ECGs demonstrates the potential of in-silico approaches for ablation guidance.
Associate Professor M. Bishop (London, GB)
Abstract Slides Video
Presentation thumbnail
Catheter ablation for the treatment of ventricular arrhythmias in the early phase following acute coronary syndrome
Doctor A. Kotinas (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular arrhythmias catheter ablation

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Radiosurgery for ventricular tachycardia (RAVENTA): Final results of a German multicenter multiplatform feasibility trial
thumbnail
Congress Presentation
Preliminary results of the non-invasive cardiac radioablation for ventricular tachycardia study; an in silico dosimetric comparison of photon vs proton radiotherapy for ventricular arrhythmias
thumbnail
Congress Presentation
Stereotactic arrhythmia radioablation in refractory ventricular tachycardia: a systematic review and meta-analysis of efficacy and survival outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources